LARIMAR THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable
LARIMAR THERAPEUTICS, INC. (LRMR) reported Increase (Decrease) in Accounts Payable of $2.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-04
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$557.00K, a 129.75% decline year-over-year.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $2.92M.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$5.83M, a 890.38% decline year-over-year.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $6.90M.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2025 was $2.79M, a 144.70% increase from fiscal 2024.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2024 was $1.14M.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2023 was -$403.00K, a 1650.00% decline from fiscal 2022.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2022 was $26.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$557.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.37M 10-Q · filed 2026-08-04 | -$3.46M derived: sum of 3 quarters · filed 2026-08-04 | $3.44M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $2.92M 10-Q · filed 2026-05-14 | -$2.91M derived: sum of 2 quarters · filed 2026-05-14 | $4.00M derived: sum of 3 quarters · filed 2026-05-14 | $5.87M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $1.07M derived: sum of 2 quarters · filed 2026-03-19 | $2.94M derived: sum of 3 quarters · filed 2026-08-04 | $2.79M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | $6.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $8.78M derived: sum of 2 quarters · filed 2026-08-04 | $8.63M 10-Q · filed 2025-11-05 | $9.36M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.72M 10-Q · filed 2026-08-04 | $2.46M derived: sum of 3 quarters · filed 2026-08-04 | $1.24M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | -$150.00K 10-Q · filed 2026-05-14 | $588.00K derived: sum of 2 quarters · filed 2026-05-14 | -$635.00K derived: sum of 3 quarters · filed 2026-05-14 | $701.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $738.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$485.00K derived: sum of 2 quarters · filed 2026-03-19 | $851.00K derived: sum of 3 quarters · filed 2026-03-19 | $1.14M 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | -$1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $113.00K derived: sum of 2 quarters · filed 2025-11-05 | $403.00K 10-Q · filed 2025-11-05 | $930.00K derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.63M 10-Q · filed 2025-08-14 | $2.15M derived: sum of 3 quarters · filed 2025-08-14 | $565.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $290.00K 10-Q · filed 2025-04-30 | $817.00K derived: sum of 2 quarters · filed 2025-04-30 | -$771.00K derived: sum of 3 quarters · filed 2025-04-30 | $878.00K derived: sum of 4 quarters · filed 2025-04-30 | ||||
| 2023-12-31 | $527.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$1.06M derived: sum of 2 quarters · filed 2025-03-24 | $588.00K derived: sum of 3 quarters · filed 2025-03-24 | -$403.00K 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | -$1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $61.00K derived: sum of 2 quarters · filed 2024-10-30 | -$930.00K 10-Q · filed 2024-10-30 | -$13.00K derived: sum of 4 quarters · filed 2024-10-30 | ||||
| 2023-06-30 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $658.00K 10-Q · filed 2024-08-08 | $1.57M derived: sum of 3 quarters · filed 2024-08-08 | $1.92M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$991.00K 10-Q · filed 2024-05-09 | -$74.00K derived: sum of 2 quarters · filed 2024-05-09 | $270.00K derived: sum of 3 quarters · filed 2024-05-09 | -$1.62M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $917.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $1.26M derived: sum of 2 quarters · filed 2024-03-14 | -$631.00K derived: sum of 3 quarters · filed 2024-03-14 | $26.00K 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $344.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.55M derived: sum of 2 quarters · filed 2023-11-14 | -$891.00K 10-Q · filed 2023-11-14 | -$988.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.24M 10-Q · filed 2023-08-10 | -$1.33M derived: sum of 3 quarters · filed 2023-08-10 | -$743.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $657.00K 10-Q · filed 2023-05-15 | $560.00K derived: sum of 2 quarters · filed 2023-05-15 | $1.15M derived: sum of 3 quarters · filed 2023-05-15 | -$881.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $492.00K derived: sum of 2 quarters · filed 2023-03-14 | -$1.54M derived: sum of 3 quarters · filed 2023-03-14 | -$974.00K 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | $589.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.44M derived: sum of 2 quarters · filed 2022-11-10 | -$877.00K 10-Q · filed 2022-11-10 | $28.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$1.47M 10-Q · filed 2022-08-11 | -$561.00K derived: sum of 3 quarters · filed 2022-08-11 | -$1.47M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $564.00K 10-Q · filed 2022-05-12 | $1.47M derived: sum of 2 quarters · filed 2022-05-12 | $560.00K derived: sum of 3 quarters · filed 2022-05-12 | -$200.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $905.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | -$4.00K derived: sum of 2 quarters · filed 2022-03-25 | -$764.00K derived: sum of 3 quarters · filed 2022-03-25 | -$3.29M 10-K · filed 2022-03-25 | ||||
| 2020-09-30 | -$909.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.67M derived: sum of 2 quarters · filed 2021-11-12 | -$4.19M 10-Q · filed 2021-11-12 | -$3.77M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$760.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$3.28M 10-Q · filed 2021-08-12 | -$2.86M derived: sum of 3 quarters · filed 2021-08-12 | -$1.31M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$2.52M 10-Q · filed 2021-05-10 | -$310.00K 10-Q · filed 2020-05-07 | -$2.10M derived: sum of 2 quarters · filed 2021-05-10 | -$547.00K derived: sum of 3 quarters · filed 2021-05-10 | $551.00K derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $426.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $1.98M derived: sum of 2 quarters · filed 2021-03-04 | $3.08M derived: sum of 3 quarters · filed 2021-03-04 | $2.63M 10-K · filed 2021-03-04 | -$2.96M 10-K · filed 2020-03-05 | |||
| 2019-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $2.65M derived: sum of 2 quarters · filed 2020-11-12 | $2.20M 10-Q · filed 2020-11-12 | -$556.00K 10-Q · filed 2019-11-06 | $3.03M derived: sum of 4 quarters · filed 2020-11-12 | |||
| 2019-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $653.00K 10-Q · filed 2020-08-14 | -$1.59M 10-Q · filed 2019-08-08 | $1.48M derived: sum of 3 quarters · filed 2020-08-14 | $1.24M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | -$445.00K 10-Q · filed 2020-05-07 | $384.00K derived: sum of 2 quarters · filed 2020-05-07 | $137.00K derived: sum of 3 quarters · filed 2020-05-07 | -$789.00K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $829.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $582.00K derived: sum of 2 quarters · filed 2020-03-05 | -$344.00K derived: sum of 3 quarters · filed 2020-03-05 | $432.00K 10-K · filed 2020-03-05 | ||||
| 2018-09-30 | -$247.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$1.17M derived: sum of 2 quarters · filed 2019-11-06 | -$397.00K 10-Q · filed 2019-11-06 | -$53.00K derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2018-06-30 | -$926.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$150.00K 10-Q · filed 2019-08-08 | $194.00K derived: sum of 3 quarters · filed 2020-03-05 | -$1.58M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2018-03-31 | $776.00K 10-Q · filed 2019-05-09 | $1.12M derived: sum of 2 quarters · filed 2020-03-05 | -$651.00K derived: sum of 3 quarters · filed 2020-03-05 | $1.89M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2017-12-31 | $344.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | -$1.43M derived: sum of 2 quarters · filed 2020-03-05 | $1.11M derived: sum of 3 quarters · filed 2020-03-05 | $448.00K 10-K · filed 2020-03-05 | ||||
| 2017-09-30 | -$1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $766.00K derived: sum of 2 quarters · filed 2018-11-09 | $104.00K 10-Q · filed 2018-11-09 | -$964.00K derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.88M 10-Q · filed 2018-08-09 | $807.00K derived: sum of 3 quarters · filed 2019-03-14 | $1.96M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-03-31 | -$662.00K 10-Q · filed 2018-05-10 | -$1.73M derived: sum of 2 quarters · filed 2019-03-14 | -$577.00K derived: sum of 3 quarters · filed 2019-03-14 | -$1.24M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2016-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $85.00K derived: sum of 2 quarters · filed 2019-03-14 | -$574.00K derived: sum of 3 quarters · filed 2019-03-14 | -$4.63M 10-K · filed 2019-03-14 | ||||
| 2016-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $494.00K derived: sum of 2 quarters · filed 2017-11-07 | -$3.56M 10-Q · filed 2017-11-07 | -$484.00K derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-06-30 | -$659.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$4.71M 10-Q · filed 2017-08-09 | -$1.64M derived: sum of 3 quarters · filed 2018-03-09 | -$1.81M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-03-31 | -$4.05M 10-Q · filed 2017-05-09 | -$978.00K derived: sum of 2 quarters · filed 2018-03-09 | -$1.15M derived: sum of 3 quarters · filed 2018-03-09 | -$258.00K derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2015-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $2.90M derived: sum of 2 quarters · filed 2018-03-09 | $3.79M derived: sum of 3 quarters · filed 2018-03-09 | $4.91M 10-K · filed 2018-03-09 | ||||
| 2015-09-30 | -$173.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $720.00K derived: sum of 2 quarters · filed 2016-11-09 | $1.84M 10-Q · filed 2016-11-09 | $3.07M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-06-30 | $893.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $2.01M 10-Q · filed 2016-08-05 | $3.25M derived: sum of 3 quarters · filed 2017-03-10 | $2.73M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-03-31 | $1.12M 10-Q · filed 2016-05-10 | $2.35M derived: sum of 2 quarters · filed 2017-03-10 | $1.84M derived: sum of 3 quarters · filed 2017-03-10 | $2.45M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2014-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $718.00K derived: sum of 2 quarters · filed 2017-03-10 | $1.33M derived: sum of 3 quarters · filed 2017-03-10 | $815.00K 10-K · filed 2017-03-10 | ||||
| 2014-09-30 | -$513.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $95.00K derived: sum of 2 quarters · filed 2015-11-13 | -$416.00K 10-Q · filed 2015-11-13 | -$301.00K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | $608.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $97.00K 10-Q · filed 2015-08-14 | $212.00K derived: sum of 3 quarters · filed 2016-03-15 | $849.00K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | -$511.00K 10-Q · filed 2015-05-14 | -$396.00K derived: sum of 2 quarters · filed 2016-03-15 | $241.00K derived: sum of 3 quarters · filed 2016-03-15 | |||||
| 2013-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $752.00K derived: sum of 2 quarters · filed 2016-03-15 | $237.00K 10-K · filed 2016-03-15 | |||||
| 2013-09-30 | $637.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $122.00K 10-Q · filed 2014-11-13 | ||||||
| 2013-06-30 | -$515.00K 10-Q · filed 2014-08-14 | |||||||
| 2012-12-31 | $727.00K 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |